CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Other financial service activities, except insurance and pension funding activities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory News Service
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
Post-Annual General Meeting Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory News Service
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AUGMENTUM FINTECH PLC Logo
A public VC firm investing exclusively in early-stage UK & European fintech businesses.
United Kingdom AUGM
Baltic Bridge S.A. Logo
An investment firm focused on Private Equity, Venture Capital, and developing its own ventures.
Poland WIS
Belreca NV Logo
An investment firm managing long-term equity stakes in public and private companies.
Belgium BELR
Beluga NV Logo
A former private equity and venture capital firm for SMEs, now in liquidation.
Belgium BELU
Bewi Invest AS Logo
Acquires and develops Nordic SMEs in industrials, seafood, and industrial real estate.
Norway BEWI
bioXXmed AG Logo
A biomedical investor financing dermatology, wound care, and regenerative medicine firms.
Germany T5O
BİRİKİM VARLIK YÖNETİM A.Ş. Logo
Acquires and manages non-performing loans from financial institutions via debt restructuring.
Türkiye BRKVY
Bitcoin Group SE Logo
A holding company and VC investor in crypto/blockchain, operating a digital asset platform.
Germany ADE
Black Pearl Spolka Akcyjna Logo
Invests in Polish tech/life science SMEs using capital and its own cryptocurrency.
Poland BPC
Blue Cap AG Logo
Investment firm that acquires, transforms, and sells medium-sized B2B niche companies.
Germany B7E

Talk to a Data Expert

Have a question? We'll get back to you promptly.